Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1681-1690 of 2762 for

Edit search filters
  1. Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction

    Rochester, MN

  2. 68GaFAPI-46 PET/CT for Pancreatic Ductal Adenocarcinoma

    Rochester, MN

  3. A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer

    Rochester, MN

  4. A Study to See if Genetic Risk Estimation of Breast Cancer Influences the Use of Preventive Medication

    Rochester, MN

  5. A Study of BBI608 Combined with Standard Chemotherapies in Adult Patients who have Pancreatic Cancer

    Scottsdale/Phoenix, AZ

  6. A Study to Measure the Impact of Continuous Positive Airway Pressure for Reducing Breathing Motion

    Rochester, MN

  7. Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)

    Scottsdale/Phoenix, AZ, Rochester, MN, Rochester, MN

  8. A Study of the Safety And Effectiveness of Palbociclib Plus Cetuximab versus Cetuximab Alone to Treat Head and Neck Cancer

    Rochester, MN

  9. A Study to Evaluate Pembrolizumab for Surgically Treated Adjuvant Merkel Cell Carcinoma

    Eau Claire, WI, Rochester, MN

  10. A Study to Evaluate the Safety and Effectiveness of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy

    Rochester, MN

.

Mayo Clinic Footer